Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/03/040830
CTRI/2022/03/040830
Completed
N/A

Home-Based Pulmonary Rehabilitation in Post Pulmonary Tuberculosis Patients

Chettinad Academy of Research and Education0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: J989- Respiratory disorder, unspecified

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: J989- Respiratory disorder, unspecified
Sponsor
Chettinad Academy of Research and Education
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Both male and female
  • •Pulmonary tuberculosis sequelae/Post pulmonary tuberculosis
  • •Patients who have access to smart phones with internet

Exclusion Criteria

  • •Age less than 18 years
  • •Smear positive PTB
  • •Treated/current Extra pulmonary TB
  • •Active hemoptysis
  • •Acute cardiac events within 6 weeks
  • •Pregnant women
  • •Severe orthopaedic impairment
  • •Cognitive impairment
  • •Unstable hemodynamic status
  • •Active infection

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
The Effect of Home Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease.Chronic obstructive pulmonary disease with acute lower respiratory infectionJ44.0
IRCT20231126060183N1Shahid Beheshti University of Medical Sciences60
Not Yet Recruiting
N/A
Home-based care for pulmonary fibrosisHealth Condition 1: J849- Interstitial pulmonary disease, unspecified
CTRI/2022/03/041284Manipal Academy Of Higher EducationMAHEKMC
Active, Not Recruiting
Phase 1
Home Treatment of Patients with Low-Risk Pulmonary Embolism with RivaroxabaAcute low-risk pulmonary embolism (PE)MedDRA version: 20.0Level: HLTClassification code 10037379Term: Pulmonary embolism and thrombosisSystem Organ Class: 100000004866Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2013-001657-28-DEniversity Medical Center of the Johannes Gutenberg University Mainz1,100
Active, Not Recruiting
Phase 1
Home Treatment of Patients with Low-Risk Pulmonary Embolism with RivaroxabaAcute low-risk pulmonary embolism (PE)MedDRA version: 20.0Level: HLTClassification code 10037379Term: Pulmonary embolism and thrombosisSystem Organ Class: 100000004866Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2013-001657-28-ITIVERSITY MEDICAL SCHOOL OF THE JOHANNES GUTENBERG UNIVERSITY MAINZ1,100
Active, Not Recruiting
Phase 1
Home Treatment of Patients with Low-Risk Pulmonary Embolism with RivaroxabaAcute low-risk pulmonary embolism (PE)MedDRA version: 20.0Level: HLTClassification code 10037379Term: Pulmonary embolism and thrombosisSystem Organ Class: 100000004866Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2013-001657-28-NLniversity Medical Center of the Johannes Gutenberg University Mainz1,100